Together, these in vivo results demonstrated that combination of si-Hotair and VEGF inhibitor exhibits strong anticancer function in LSCC tumors by inhibiting tumor growth and activating T cell-mediated immune responses. This evidence concerns the gene VEGFA and neoplasm.